News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,774 Results
Type
Article (39287)
Company Profile (248)
Press Release (651239)
Section
Business (203981)
Career Advice (2002)
Deals (35398)
Drug Delivery (89)
Drug Development (80909)
Employer Resources (169)
FDA (16120)
Job Trends (14820)
News (344791)
Policy (32465)
Tag
Academia (2530)
Alliances (49285)
Alzheimer's disease (1299)
Approvals (16089)
Artificial intelligence (179)
Bankruptcy (354)
Best Places to Work (11621)
Biotechnology (175)
Breast cancer (214)
Cancer (1588)
Cardiovascular disease (122)
Career advice (1667)
CAR-T (111)
Cell therapy (322)
Clinical research (65043)
Collaboration (606)
Compensation (313)
COVID-19 (2555)
C-suite (141)
Data (1510)
Diabetes (194)
Diagnostics (6233)
Earnings (85131)
Employer resources (146)
Events (110520)
Executive appointments (516)
FDA (16936)
Funding (548)
Gene therapy (223)
GLP-1 (633)
Government (4348)
Healthcare (18742)
Infectious disease (2653)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16423)
Job creations (3626)
Job search strategy (1419)
Layoffs (430)
Legal (7877)
Lung cancer (234)
Manufacturing (221)
Medical device (13244)
Medtech (13249)
Mergers & acquisitions (19281)
Metabolic disorders (513)
Neuroscience (1677)
NextGen: Class of 2025 (6507)
Non-profit (4473)
Northern California (1921)
Obesity (293)
Opinion (188)
Patents (138)
People (56711)
Phase I (20249)
Phase II (28645)
Phase III (21339)
Pipeline (638)
Postmarket research (2562)
Preclinical (8559)
Radiopharmaceuticals (240)
Rare diseases (299)
Real estate (5894)
Regulatory (21830)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1663)
Startups (3567)
United States (17209)
Vaccines (589)
Weight loss (200)
Date
Today (13)
Last 7 days (621)
Last 30 days (2617)
Last 365 days (34667)
2025 (2650)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55711)
2020 (54095)
2019 (46544)
2018 (35020)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (206)
Asia (37432)
Australia (6119)
California (4397)
Canada (1603)
China (369)
Colorado (198)
Connecticut (210)
Europe (80182)
Florida (633)
Georgia (154)
Illinois (432)
Indiana (249)
Maryland (697)
Massachusetts (3389)
Michigan (188)
Minnesota (321)
New Jersey (1243)
New York (1266)
North Carolina (798)
Northern California (1921)
Ohio (161)
Pennsylvania (1026)
South America (1093)
Southern California (1663)
Texas (643)
Utah (129)
Washington State (435)
690,774 Results for "chromadex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ChromaDex to Join Russell 2000® Index
ChromaDex Corp., the global authority on nicotinamide adenine dinucleotide research with a focus on healthy aging, announced its inclusion in the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes.
July 1, 2024
·
6 min read
Biotech Beach
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, June 11, 2024
ChromaDex Corp. announced today that it will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on Tuesday, June 11, 2024, at 2:00pm PST.
June 4, 2024
·
2 min read
Business
ChromaDex Corporation Reports First Quarter 2024 Financial Results
ChromaDex Corp. announced financial results for the first quarter of 2024.
May 8, 2024
·
13 min read
Press Releases
ChromaDex Corporation Reports Third Quarter 2024 Financial Results
October 31, 2024
·
15 min read
Press Releases
ChromaDex to Participate in the 17th Annual LD Micro Main Event
October 23, 2024
·
2 min read
Biotech Beach
ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
ChromaDex Corp. today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be participating in the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.
May 23, 2024
·
2 min read
Biotech Beach
ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)
ChromaDex Corp., the global authority on nicotinamide adenine dinucleotide research and its application to healthy aging, unveils Niagen+, the first-of-its-kind pharmaceutical-grade Niagen®.
June 13, 2024
·
9 min read
Press Releases
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
October 28, 2024
·
3 min read
Press Releases
ChromaDex Appoints Ozan Pamir as Chief Financial Officer
September 20, 2024
·
5 min read
Business
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
October 24, 2024
·
3 min read
1 of 69,078
Next
